Professional Documents
Culture Documents
Retained Placenta
The third stage of labour commences with the completed delivery of the fetus and ends with the completed
delivery of the placenta and its attached membranes. The length of the third stage itself is usually 5-15 minutes.
The National Institute for Health and Care Excellence (NICE) recommends that the third stage is diagnosed as
delayed if it takes longer than 30 minutes to deliver the placenta with active management or 60 minutes if allowed
to deliver the placenta physiologically with maternal effort. [1]
Retained placenta is important as it is one of the causes of postpartum haemorrhage, which is the third leading
cause of maternal mortality in the UK. [2] Retained placenta increases the risks of a postpartum haemorrhage by
five-fold (3.36-7.87; 99% confidence interval (CI)). [3]
Aetiology
There are three main types of retained placenta following vaginal delivery, which can all be treated by manual
removal of the placenta: [4]
Placenta adherens, when the myometrium fails to contract behind the placenta.
Trapped placenta, when a detached placenta is trapped behind a closed cervix.
Partial accreta, when there is a small area of adherent placenta preventing detachment.
Rarely there is an abnormality of the placenta (placenta accreta) which leads it to penetrate the myometrium to a
varying degree preventing manual removal without risking significant postpartum haemorrhage.
Epidemiology
The incidence and importance of retained placenta vary greatly around the world: [4]
In less developed countries, it affects about 0.1% of deliveries but has up to 10% case fatality rate.
In more developed countries, it is more common (about 3% of vaginal deliveries) but very rarely
associated with mortality. Retained placenta was identified as the cause of 18% of severe obstetric
haemorrhages in one American series. [5]
Management
Active management of the third stage is encouraged as it is associated with a lower risk of postpartum
haemorrhage and blood transfusion. If the labour has progressed normally and the mother requests physiological
management of the third stage, she should be supported in this request. [1, 6] However, if there has been
significant haemorrhage, try to discover if the placenta has separated - as indicated by:
If the placenta needs to be removed manually, this must be done under anaesthetic:
Place a gloved hand into the uterus, with the other hand on the fundus to control it.
Follow the umbilical cord until you find the lower edge of the placenta.
Push the hand between the placenta and the body of the uterus and ease the placenta away with a
sawing action (NB: in cases of placenta accreta, the placenta will not detach easily and use of
excessive force can result in life-threatening haemorrhage which may require hysterectomy).
When fully detached, explore the uterine cavity for damage and for other pieces of placenta.
Massage the fundus with one hand whilst extracting the placenta and membranes with the hand in the
uterine cavity.
Look carefully at the placenta to be sure that it is complete.
Inject ergometrine IV and IM.
Complications
Retained placenta is, in itself, life-threatening because of its association with infection and postpartum
haemorrhage.
Manual removal of a retained placenta is not without risk. Although it increases the likelihood of
bacterial contamination in the uterine cavity, there are no randomised controlled trials to evaluate the
effectiveness of antibiotic prophylaxis to prevent endometritis after manual removal of placenta. [7]
Prevention
Since manual removal of a retained placenta is invasive and carries risks of damage to the genital tract, infection
and haemorrhage, many attempts have been made to increase the ability of the uterus to expel a retained
placenta without recourse to surgery.
Umbilical vein injections of saline, plasma expander or prostaglandins with or without oxytocin have all
been studied. Unfortunately, a Cochrane review found no evidence of any beneficial effect of any of
these. [8] Also, NICE no longer recommends umbilical vein injection of oxytocin. [1]
There is conflicting evidence from small studies that nitroglycerine, sublingual or IV, may reduce the
need for a manual removal of retained placenta; the true effect is uncertain.
Sulprostone is a potent stimulator of uterine smooth muscle contractions with high abortifacient
activity. It is not licensed in the UK but has been shown in one small study (n=50) to reduce the need
for the manual removal of the placenta by 49% [9] and in a study of 126 women, all of whom received
sulprostone, by 39.7%.
Misoprostol does not reduce the need for manual removal for retained placenta. [10]
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical
conditions. EMIS has used all reasonable care in compiling the information but makes no warranty as to its
accuracy. Consult a doctor or other healthcare professional for diagnosis and treatment of medical conditions.
For details see our conditions.